Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Percutaneous closure of pulmonary arteriovenous malformation and concomitant patent foramen ovale for cryptogenic stroke.

Autor: Dondapati M; Department of Medicine, Stony Brook University Hospital, Stony Brook, New York., Gier C; Department of Medicine, Stony Brook University Hospital, Stony Brook, New York., Ohngemach D; Department of Radiology, Stony Brook University Hospital, Stony Brook, New York., Kort S; Department of Medicine, Stony Brook University Hospital, Stony Brook, New York., Chen O; Department of Medicine, Stony Brook University Hospital, Stony Brook, New York., Parikh PB; Department of Medicine, Stony Brook University Hospital, Stony Brook, New York. Email: puja.parikh@stonybrookmedicine.edu.

Publikováno v: The Journal of invasive cardiology [J Invasive Cardiol] 2024 Nov 04. Date of Electronic Publication: 2024 Nov 04.

Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction.

Autor: Udell JA; Women's College Hospital, University of Toronto, Toronto, Ontario, Canada; Peter Munk Cardiac Centre, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada. Electronic address: jay.udell@utoronto.ca., Petrie MC; School of Cardiovascular and Medical Sciences, British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Jones WS; Division of Cardiology, Duke University Department of Medicine, Durham, North Carolina, USA; Duke University Medical Center, Duke Clinical Research Institute, Durham, North Carolina, USA., Anker SD; Department of Cardiology, German Heart Center Charité, Charité Universitätsmedizin, Berlin, Germany; Berlin Institute of Health Center for Regenerative Therapies, German Centre for Cardiovascular Research partner site Berlin, Charité Universitätsmedizin, Berlin, Germany., Harrington J; Division of Cardiology, Duke University Department of Medicine, Durham, North Carolina, USA; Duke University Medical Center, Duke Clinical Research Institute, Durham, North Carolina, USA., Mattheus M; Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany., Seide S; Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany., Amir O; Heart Institute, Hadassah Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel., Bahit MC; INECO Neurociencias Oroño, Fundación INECO, Rosario, Santa Fe, Argentina., Bauersachs J; Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany., Bayes-Genis A; Heart Institute, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain; Department of Medicine, Universitat Autònomoa de Barcelona, Barcelona, Spain., Chen Y; Department of Cardiology, the First Medical Center of Chinese PLA General Hospital, Beijing, China., Chopra VK; Max Super Speciality Hospital, Saket, New Delhi, India., Figtree G; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia., Ge J; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, China., Goodman SG; Peter Munk Cardiac Centre, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada; Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada; Division of Cardiology, Department of Medicine, St Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada., Gotcheva N; Department of Cardiology, MHAT National Cardiology Hospital EAD, Sofia, Bulgaria., Goto S; Department of Medicine (Cardiology), Tokai University School of Medicine, Isehara, Japan., Gasior T; Collegium Medicum - Faculty of Medicine, WSB University, Dabrowa Gornicza, Poland; Boehringer Ingelheim International GmbH, Ingelheim, Germany., Jamal W; Boehringer Ingelheim International GmbH, Ingelheim, Germany., Januzzi JL; Division of Cardiology, Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts, USA; Heart Failure and Biomarker Trials, Baim Institute for Clinical Research, Boston, Massachusetts, USA., Jeong MH; Chonnam National University Hospital and Medical School, Gwangju, Republic of Korea., Lopatin Y; Volgograd State Medical University, Volgograd, Russia., Lopes RD; Division of Cardiology, Duke University Department of Medicine, Durham, North Carolina, USA; Duke University Medical Center, Duke Clinical Research Institute, Durham, North Carolina, USA., Merkely B; Heart and Vascular Center, Semmelweis University, Budapest, Hungary., Martinez-Traba M; Boehringer Ingelheim International GmbH, Ingelheim, Germany., Parikh PB; Division of Cardiovascular Medicine, Department of Medicine, State University of New York at Stony Brook, Stony Brook, New York, USA., Parkhomenko A; M.D. Strazhesko Ukrainian Institute of Cardiology, AMS Ukraine, Kyiv, Ukraine., Ponikowski P; Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland., Rossello X; Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain., Schou M; Department of Cardiology, Herlev and Gentofte University Hospital, Copenhagen, Denmark., Simic D; Department of Cardiovascular Diseases, University Clinical Center, Belgrade, Serbia., Steg PG; Université Paris-Cité, FACT (French Alliance for Cardiovascular Trials), INSERM U-1148, AP-HP, Hôpital Bichat, Paris, France., Szachniewicz J; Jan Mikulicz-Radecki University Clinical Hospital, Wroclaw, Poland., van der Meer P; Department of Cardiology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands., Vinereanu D; University of Medicine and Pharmacy Carol Davila, University and Emergency Hospital of Bucharest, Bucharest, Romania., Zieroth S; Section of Cardiology, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada., Brueckmann M; Boehringer Ingelheim International GmbH, Ingelheim, Germany; First Department of Medicine, Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany., Sumin M; Boehringer Ingelheim International GmbH, Ingelheim, Germany., Bhatt DL; Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Hernandez AF; Division of Cardiology, Duke University Department of Medicine, Durham, North Carolina, USA; Duke University Medical Center, Duke Clinical Research Institute, Durham, North Carolina, USA., Butler J; Baylor Scott and White Research Institute, Dallas, Texas, USA; Department of Medicine, University of Mississippi, Jackson, Mississippi, USA.

Publikováno v: Journal of the American College of Cardiology [J Am Coll Cardiol] 2024 Jun 11; Vol. 83 (23), pp. 2233-2246. Date of Electronic Publication: 2024 Apr 06.

Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial.

Autor: Hernandez AF; Duke University Department of Medicine, Division of Cardiology, and Duke Clinical Research Institute, Durham, NC (A.F.H., W.S.J., J.H., R.D.L.)., Udell JA; Women's College Hospital and Peter Munk Cardiac Centre, Toronto General Hospital, University of Toronto, Canada (J.A.U.)., Jones WS; Duke University Department of Medicine, Division of Cardiology, and Duke Clinical Research Institute, Durham, NC (A.F.H., W.S.J., J.H., R.D.L.)., Anker SD; Department of Cardiology (CVK) of German Heart Center Charité, Berlin Institute of Health Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) partner site Berlin, Charité Universitätsmedizin, Berlin, Germany (S.D.A.)., Petrie MC; School of Cardiovascular and Medical Sciences, British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, UK (M.C.P.)., Harrington J; Duke University Department of Medicine, Division of Cardiology, and Duke Clinical Research Institute, Durham, NC (A.F.H., W.S.J., J.H., R.D.L.)., Mattheus M; Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany (M.M., S.S., I.Z.)., Seide S; Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany (M.M., S.S., I.Z.)., Zwiener I; Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany (M.M., S.S., I.Z.)., Amir O; Heart Institute, Hadassah Medical Center, The Hebrew University of Jerusalem, Israel (O.A.)., Bahit MC; INECO Neurociencias Oroño, Fundación INECO, Rosario, Santa Fe, Argentina (M.C.B.)., Bauersachs J; Department of Cardiology and Angiology, Hannover Medical School, Germany (J. Bauersachs)., Bayes-Genis A; Heart Institute, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain (A.B.-G.).; Department of Medicine, Universitat Autònomoa de Barcelona, Spain (A.B.-G.)., Chen Y; Department of Cardiology, the First Medical Center of Chinese PLA General Hospital, Beijing, China (Y.C.)., Chopra VK; Max Super Speciality Hospital, Saket, New Delhi, India (V.K.C.)., A Figtree G; Faculty of Medicine and Health, University of Sydney, Australia (G.A.F.)., Ge J; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, China (J.G.)., G Goodman S; Canadian VIGOUR Centre, University of Alberta, Edmonton, Canada (S.G.G.).; Division of Cardiology, Department of Medicine, St Michael's Hospital, Unity Health Toronto and Peter Munk Cardiac Centre, University Health Network, University of Toronto, Canada (S.G.G.)., Gotcheva N; Department of Cardiology, MHAT 'National Cardiology Hospital' EAD, Sofia, Bulgaria (N.G.)., Goto S; Department of Medicine (Cardiology), Tokai University School of Medicine, Isehara, Japan (S.G.)., Gasior T; Boehringer Ingelheim International GmbH, Ingelheim, Germany (T.G., W.J., M.B., M. Sumin).; Collegium Medicum, Faculty of Medicine, WSB University, Dabrowa Gornicza, Poland (T.G.)., Jamal W; Boehringer Ingelheim International GmbH, Ingelheim, Germany (T.G., W.J., M.B., M. Sumin)., Januzzi JL; Division of Cardiology, Harvard Medical School and Massachusetts General Hospital, Boston (J.L.J.)., Jeong MH; Chonnam National University Hospital and Medical School, Gwangju, Republic of Korea (M.H.J.)., Lopatin Y; Volgograd State Medical University, Russia (Y.L.)., Lopes RD; Duke University Department of Medicine, Division of Cardiology, and Duke Clinical Research Institute, Durham, NC (A.F.H., W.S.J., J.H., R.D.L.)., Merkely B; Heart and Vascular Center, Semmelweis University, Budapest, Hungary (B.M.)., Parikh PB; Division of Cardiovascular Medicine, Department of Medicine, State University of New York at Stony Brook (P.B.P.)., Parkhomenko A; The Ukrainian Institute of Cardiology na MD Strazhesko, AMS Ukraine, Kyiv (A.P.)., Ponikowski P; Institute of Heart Diseases, Wroclaw Medical University, Poland (P.P.)., Rossello X; Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.)., Schou M; Department of Cardiology, Herlev and Gentofte University Hospital, Copenhagen, Denmark (M. Schou)., Simic D; Department of Cardiovascular Diseases, University Clinical Center Belgrade, Serbia (D.S.)., Steg PG; Université Paris-Cité, FACT (French Alliance for Cardiovascular Trials), INSERM U-1148, AP-HP, Hôpital Bichat, Paris, France (P.G.S.)., Szachniewicz J; Jan Mikulicz-Radecki University Clinical Hospital, Wroclaw, Poland (J.S.)., van der Meer P; Department of Cardiology, University of Groningen, University Medical Centre Groningen, the Netherlands (P.v.d.M.)., Vinereanu D; University of Medicine and Pharmacy Carol Davila, University and Emergency Hospital, Bucharest, Romania (D.V.)., Zieroth S; Section of Cardiology, Max Rady College of Medicine, University of Manitoba, Winnipeg, Canada (S.Z.)., Brueckmann M; Boehringer Ingelheim International GmbH, Ingelheim, Germany (T.G., W.J., M.B., M. Sumin).; First Department of Medicine, Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany (M.B.)., Sumin M; Boehringer Ingelheim International GmbH, Ingelheim, Germany (T.G., W.J., M.B., M. Sumin)., Bhatt DL; Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, NY (D.L.B.)., Butler J; Baylor Scott and White Research Institute, Dallas, TX (J. Butler).; Department of Medicine, University of Mississippi, Jackson (J. Butler).

Publikováno v: Circulation [Circulation] 2024 May 21; Vol. 149 (21), pp. 1627-1638. Date of Electronic Publication: 2024 Apr 06.